Notably, following the systemic administration of GRP78 or its analog IRL201805 in an animal model of rheumatoid arthritis, these proteins are rapidly internalized by monocytes, which eventually leads to an increased secretion of IL-10 and the suppression of TNF-α and IL-1β release [37]. This evidence concerns the gene IL10 and rheumatoid arthritis.